EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 23 / No 8-9 (Août-Septembre 2007) Med Sci (Paris), 23 8-9 (2007) 690-691 References
Free Access
Issue
Med Sci (Paris)
Volume 23, Number 8-9, Août-Septembre 2007
Page(s) 690 - 691
Section Nouvelles
DOI https://doi.org/10.1051/medsci/20072389690
Published online 15 August 2007
  1. Huebner RJ, Todaro GJ. Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci USA 1969; 64 : 1087–94. [Google Scholar]
  2. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100 : 57–70. [Google Scholar]
  3. Pagano JS, Blaser M, Buendia MA, et al. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 2004; 14 : 453–71. [Google Scholar]
  4. Munger K, Howley PM. Human papillomavirus immortalization and transformation functions. Virus Res 2002; 89 : 213–28. [Google Scholar]
  5. Moradpour D, Penin F, Rice CM. Replication of hepatitis C virus. Nat Rev Microbiol 2007; 5 : 453–63. [Google Scholar]
  6. Marriott SJ, Semmes OJ. Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response. Oncogene 2005; 24 : 5986–95. [Google Scholar]
  7. Thrasher AJ, Hacein-Bey-Abina S, Gaspar HB, et al. Failure of SCID-X1 gene therapy in older patients. Blood 2005; 105 : 4255–7. [Google Scholar]
  8. Darlix JL, Cristofari G, Rau M, et al. Nucleocapsid protein of human immunodeficiency virus as a model protein with chaperoning functions and as a target for antiviral drugs. Adv Pharmacol 2000; 48 : 345–72. [Google Scholar]
  9. Sitbon M, Denesvre C, Dardalhon V, et al. Les rétrovirus leucémogènes murins : pathogènes, gènes et outils génétiques. Virologie 2001; 5 : 265–93. [Google Scholar]
  10. Rosenberg N, Jolicoeur P. Retroviruses. In : Coffin J, Hughes SH, Varmus HE, eds. Cold Spring Harbor, NY : Cold Spring Harbor Laboratory Press, 1997 : 475–585. [Google Scholar]
  11. Urisman A, Molinaro RJ, Fischer N, et al. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006; 2 : e25. [Google Scholar]
  12. Dong B, Kim S, Hong S, et al. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci USA 2007; 104 : 1655–60. [Google Scholar]
  13. Fan H. A new human retrovirus associated with prostate cancer. Proc Natl Acad Sci USA 2007; 104 : 1449–50. [Google Scholar]
  14. Casey G, Neville PJ, Plummer SJ, et al. RNASEL Arg462Gln variant is implicated in up to 13 % of prostate cancer cases. Nat Genet 2002; 32 : 581–3. [Google Scholar]
  15. Thakur CS, Jha BK, Dong B, et al. Small-molecule activators of RNase L with broad-spectrum antiviral activity. Proc Natl Acad Sci USA 2007; 104 : 9585–90. [Google Scholar]
  16. Battini JL, Rasko JE, Miller AD. A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction. Proc Natl Acad Sci USA 1999; 96 : 1385–90. [Google Scholar]
  17. Corbin A, Prats AC, Darlix JL, Sitbon M. A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses. J Virol 1994; 68 : 3857–67. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.